Pan-EU RWD Network To Support EMA Evaluations Draws Nearer
First DARWIN EU Pilot Studies To Be Delivered In 2022
Executive Summary
Efforts to set up an EU-wide network of real-world data sources to support medicines evaluation are gathering pace.
You may also be interested in...
DARWIN EU: The Go-To Place For Real World Data
An EU-wide network of real-world data sources will aim to become the dominant vehicle for delivering such evidence to the EMA and member countries, who have until now been using a wide range of different sources to access such data.
EMA Lays Out Plans For Routine Use Of Real-World Evidence
A panel of regulators overseeing the implementation of several big data projects within the EU medicines network has given details of real-world evidence integration pilots to be undertaken next year by various European Medicines Agency scientific committees.
EMA Scouts Market To Procure Sentinel-Style RWD Database
The European Medicines Agency is inviting feedback from organizations interested in setting up and operating an EU-wide database network and healthcare data analysis platform.